Mroczkowska-Bekarciak A, Wrobel T
Oncotarget. 2025; 16:44-50.
PMID: 39907609
PMC: 11798483.
DOI: 10.18632/oncotarget.28686.
Lin C, Schwarzbach A, Sanz J, Montesinos P, Stiff P, Parikh S
Transplant Cell Ther. 2023; 29(5):338.e1-338.e6.
PMID: 36775201
PMC: 10149622.
DOI: 10.1016/j.jtct.2023.01.031.
Deshmukh K, Kelemen K
Life (Basel). 2022; 12(4).
PMID: 35455050
PMC: 9028156.
DOI: 10.3390/life12040559.
Plesa A, Tigaud I, Hayette S, Roumier C, Thomas X
Oncol Ther. 2022; 10(1):75-84.
PMID: 35129793
PMC: 9098757.
DOI: 10.1007/s40487-021-00180-2.
Williams L, Doucette K, Karp J, Lai C
Bone Marrow Transplant. 2021; 56(7):1535-1549.
PMID: 33686252
DOI: 10.1038/s41409-021-01214-z.
Jumping translocations of 1q in donor cell-derived myelodysplastic syndrome after cord blood transplantation: Case report and review of the literature.
Kondo T, Tasaka T, Shimizu R, Hayashi K, Yamada S, Fukuda H
Mol Clin Oncol. 2020; 12(4):365-373.
PMID: 32190321
PMC: 7058023.
DOI: 10.3892/mco.2020.1995.
Backtracked analysis of preleukemic fusion genes and DNA repair foci in umbilical cord blood of children with acute leukemia.
Skorvaga M, Durdik M, Kosik P, Markova E, Holop M, Kubes M
Oncotarget. 2018; 9(27):19233-19244.
PMID: 29721197
PMC: 5922391.
DOI: 10.18632/oncotarget.24976.
National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: The Subsequent Neoplasms Working Group Report.
Morton L, Saber W, Baker K, Barrett A, Bhatia S, Engels E
Biol Blood Marrow Transplant. 2016; 23(3):367-378.
PMID: 27634019
PMC: 5285307.
DOI: 10.1016/j.bbmt.2016.09.005.
Donor Cell Myeloid Sarcoma in an Umbilical Cord Transplant Patient: A Case Report and a Review of the Literature.
Hayes C, Petersen B, Malone A
Case Rep Hematol. 2016; 2015:186869.
PMID: 26823986
PMC: 4707376.
DOI: 10.1155/2015/186869.
Donor cell-derived leukemia after cord blood transplantation and a review of the literature: differences between cord blood and BM as the transplant source.
Shiozaki H, Yoshinaga K, Kondo T, Imai Y, Shiseki M, Mori N
Bone Marrow Transplant. 2013; 49(1):102-9.
PMID: 24013690
DOI: 10.1038/bmt.2013.127.
Donor cell leukemia after umbilical cord blood transplantation: recurrent or de novo? The importance of diagnosis for therapeutic decision making.
Shono Y, Kosugi-Kanaya M, Shiratori S, Sugita J, Fujimoto K, Kondo T
Int J Hematol. 2011; 93(4):563-565.
PMID: 21479587
DOI: 10.1007/s12185-011-0814-y.
Donor cell leukemia in umbilical cord blood transplant patients: a case study and literature review highlighting the importance of molecular engraftment analysis.
Crow J, Youens K, Michalowski S, Perrine G, Emhart C, Johnson F
J Mol Diagn. 2010; 12(4):530-7.
PMID: 20431036
PMC: 2893640.
DOI: 10.2353/jmoldx.2010.090215.
Risks and mechanisms of oncological disease following stem cell transplantation.
Anisimov S, Morizane A, Correia A
Stem Cell Rev Rep. 2010; 6(3):411-24.
PMID: 20300888
DOI: 10.1007/s12015-010-9134-5.
